Detalhe da pesquisa
1.
Individual thrombin generation and spontaneous bleeding rate during personalized prophylaxis with Nuwiq® (human-cl rhFVIII) in previously treated patients with severe haemophilia A.
Haemophilia
; 24(4): 619-627, 2018 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-29855112
2.
Postauthorization safety study of Clottafact® , a triply secured fibrinogen concentrate in acquired fibrinogen deficiency: a prospective observational study.
Vox Sang
; 113(2): 120-127, 2018 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-29238971
3.
First report on the safety and efficacy of an extended half-life glycoPEGylated recombinant FVIII for major surgery in severe haemophilia A.
Haemophilia
; 23(5): 689-696, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28470862
4.
Molecular cytogenetic characterization of five F8 complex rearrangements: utility for haemophilia A genetic counselling.
Haemophilia
; 23(4): e316-e323, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28475226
5.
Pharmacokinetics of a novel extended half-life glycoPEGylated factor IX, nonacog beta pegol (N9-GP) in previously treated patients with haemophilia B: results from two phase 3 clinical trials.
Haemophilia
; 23(4): 547-555, 2017 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-28233381
6.
Target plasma factor levels for personalized treatment in haemophilia: a Delphi consensus statement.
Haemophilia
; 23(3): e170-e179, 2017 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-28345268
7.
Dosing regimens, FVIII levels and estimated haemostatic protection with special focus on rFVIIIFc.
Haemophilia
; 22(3): 389-96, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26863900
8.
Recombinant long-acting glycoPEGylated factor IX (nonacog beta pegol) in haemophilia B: assessment of target joints in multinational phase 3 clinical trials.
Haemophilia
; 22(4): 507-13, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26936227
9.
Characterization of five associations of F8 missense mutations containing FVIII B domain mutations.
Haemophilia
; 22(4): 583-9, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-26915717
10.
The association of haemophilic arthropathy with Health-Related Quality of Life: a post hoc analysis.
Haemophilia
; 22(6): 833-840, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27785891
11.
Efficacy and safety of long-acting recombinant fusion protein linking factor IX with albumin in haemophilia B patients undergoing surgery.
Haemophilia
; 22(4): e259-66, 2016 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-27333467
12.
Achievements, challenges and unmet needs for haemophilia patients with inhibitors: Report from a symposium in Paris, France on 20 November 2014.
Haemophilia
; 22 Suppl 1: 1-24, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26728503
13.
Post-authorization safety study of Clottafact® , a triply secured fibrinogen concentrate in congenital afibrinogenemia. A prospective observational study.
Vox Sang
; 111(4): 383-390, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27583698
14.
Spotlight on the human factor: building a foundation for the future of haemophilia A management: report from a symposium on human recombinant FVIII at the World Federation of Hemophilia World Congress, Melbourne, Australia on 12 May 2014.
Haemophilia
; 21 Suppl 1: 1-12, 2015 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-25472812
15.
FEIBA in the treatment of acquired haemophilia A: results from the prospective multicentre French 'FEIBA dans l'hémophilie A acquise' (FEIBHAC) registry.
Haemophilia
; 21(3): 330-337, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25359571
16.
In vivo efficacy of human recombinant factor IX produced by the human hepatoma cell line HuH-7.
Haemophilia
; 21(4): e317-21, 2015 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-25981983
17.
Usefulness of an in vitro cellular expression model for haemophilia A carrier diagnosis: illustration with five novel mutations in the F8 gene in women with isolated factor VIII:C deficiency.
Haemophilia
; 21(3): e202-e209, 2015 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-25708597
18.
The first recombinant FVIII produced in human cells--an update on its clinical development programme.
Haemophilia
; 20 Suppl 1: 1-9, 2014 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-24330348
19.
Characterization of four novel molecular changes in the promoter region of the factor VIII gene.
Haemophilia
; 20(2): e149-56, 2014 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-24372689
20.
Diagnosis and management challenges in patients with mild haemophilia A and discrepant FVIII measurements.
Haemophilia
; 20(4): 550-8, 2014 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-24517184